Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.2B | 8.4B | 8.5B | 8.8B |
| Cost of revenue | 6.0B | 6.4B | 6.3B | 6.6B |
| Gross profit | 2.2B | 2.0B | 2.2B | 2.2B |
| Operating expense | ||||
| Research & development | 344M | 356M | 359M | 379M |
| Selling general and admin | 754M | 801M | 807M | 830M |
| Other operating expenses | 5M | 181M | 10M | 11M |
| Operating income | 1.0B | 664M | 963M | 940M |
| Non operating interest income | ||||
| Income | 60M | 34M | 47M | 53M |
| Expense | 77M | 89M | 83M | 109M |
| Other income expense | 114M | 53M | 116M | 93M |
| Pretax income | 1.1B | 662M | 1.0B | 977M |
| Tax provision | 267M | 217M | 200M | 225M |
| Net income | 850M | 445M | 843M | 752M |
| Basic EPS | 6.0 | 3.0 | 5.9 | 5.3 |
| Diluted EPS | 6.0 | 3.0 | 5.9 | 5.3 |
| Basic average shares | 137.6M | 137.4M | 137.2M | 137.1M |
| Diluted average shares | 138.3M | 138.4M | 138.1M | 137.9M |
| EBITDA | 1.5B | 1.1B | 1.4B | 1.4B |
| Net income from continuing op. | 850M | 445M | 843M | 752M |
| Minority interests | -26M | -27M | -34M | -26M |
| Preferred stock dividends | — | — | — | — |